• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE Back to Search Results
Device Problems Improper or Incorrect Procedure or Method (2017); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Peritonitis (2252)
Event Date 03/26/2024
Event Type  Injury  
Manufacturer Narrative
The device was not returned and the lot number is unknown; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
A peritoneal dialysis (pd) patient experienced peritonitis manifested by abdominal pain.The cause of peritonitis was unknown.The patient was hospitalized for the event and was treated with unspecified medications.At the time of this report, the patient was discharged from the hospital and patient outcome was unknown.Action with pd therapy was unknown.No additional information is available.
 
Manufacturer Narrative
Additional information: b3, b5, b6, b7, d10, h6 and h10.B5: upon follow-up, it was reported that the patient experienced a breach in aseptic technique which resulted in bacterial peritonitis.The breach in aseptic technique was not further described.The peritonitis was manifested by cloudy effluent.The same day as the event onset, the patient was treated with ancef (1.5g, intraperitoneal, discontinued after 22 days), ceftazidime (1.5g, intraperitoneal, discontinued after 22 days) and vanco (1.5g, intraperitoneal, discontinued on the same day) for the event.At the time of this report, the patient was recovering from the event.H10: this report is for a breach in aseptic technique which resulted in peritonitis. per baxter labeling, users are instructed to use aseptic technique when performing peritoneal dialysis therapy. should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NI
Type of Device
SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE CORPORATION
ni
ni
ni
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key18986989
MDR Text Key338716644
Report Number1416980-2024-01370
Device Sequence Number1
Product Code KDJ
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
NI
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 05/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 03/05/2024
Initial Date FDA Received03/27/2024
Supplement Dates Manufacturer Received04/18/2024
Supplement Dates FDA Received05/02/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
EXTRANEAL 2L/2L TB 1 BG 7.5% TWIN; UNKNOWN BAXTER PD DISPOSABLES
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age72 YR
Patient SexMale
-
-